These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2674860

  • 1. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
    Ray D, Robert-Lézénès J.
    Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
    [Abstract] [Full Text] [Related]

  • 2. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters.
    Kohlhuber F, Strobl LJ, Eick D.
    Oncogene; 1993 Apr; 8(4):1099-102. PubMed ID: 8455938
    [Abstract] [Full Text] [Related]

  • 3. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R, Nepveu A, Marcu KB, McBurney MW.
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [Abstract] [Full Text] [Related]

  • 4. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D, Tavassoli M, Linskens MH, Farzaneh F.
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [Abstract] [Full Text] [Related]

  • 5. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV, Kukowska J.
    Nature; 1989 Feb; 322(6082):848-50. PubMed ID: 3528863
    [Abstract] [Full Text] [Related]

  • 6. Analysis of c-myc expression in a human hepatoma cell line.
    Huber BE, Thorgeirsson SS.
    Cancer Res; 1987 Jul 01; 47(13):3414-20. PubMed ID: 3034414
    [Abstract] [Full Text] [Related]

  • 7. Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement.
    Ray D, Meneceur P, Tavitian A, Robert-Lezenes J.
    Mol Cell Biol; 1987 Feb 01; 7(2):940-5. PubMed ID: 3547087
    [Abstract] [Full Text] [Related]

  • 8. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
    Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S.
    Nature; 1987 Feb 01; 322(6081):748-50. PubMed ID: 3528861
    [Abstract] [Full Text] [Related]

  • 9. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D, Polack A, Kofler E, Bornkamm GW.
    Oncogene; 1988 Oct 01; 3(4):397-403. PubMed ID: 3078949
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM, Ramsay RG, Rifkind RA, Marks PA.
    Oncogene; 1989 Feb 01; 4(2):165-73. PubMed ID: 2648254
    [Abstract] [Full Text] [Related]

  • 11. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H, Watanabe T, Nomura S, Oishi M.
    Jpn J Cancer Res; 1987 Aug 01; 78(8):776-9. PubMed ID: 3115922
    [Abstract] [Full Text] [Related]

  • 12. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression.
    Re GG, Antoun GR, Zipf TF.
    Oncogene; 1990 Aug 01; 5(8):1247-50. PubMed ID: 1697411
    [Abstract] [Full Text] [Related]

  • 13. A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA.
    Watson RJ.
    Oncogene; 1988 Mar 01; 2(3):267-72. PubMed ID: 3281094
    [Abstract] [Full Text] [Related]

  • 14. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
    Chang Y, Spicer DB, Sonenshein GE.
    Oncogene; 1991 Nov 01; 6(11):1979-82. PubMed ID: 1682864
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M, Boss GR, Pascual FE, Pilz RB.
    Cell Growth Differ; 1995 Dec 01; 6(12):1559-66. PubMed ID: 9019161
    [Abstract] [Full Text] [Related]

  • 16. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
    Gai XX, Rizzo MG, Valpreda S, Baserga R.
    Oncogene Res; 1989 Dec 01; 5(2):111-20. PubMed ID: 2691956
    [Abstract] [Full Text] [Related]

  • 17. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T, Sherman M, Shafman T, Iwata T, Kufe D.
    J Cell Physiol; 1986 Jun 01; 127(3):480-4. PubMed ID: 3458709
    [Abstract] [Full Text] [Related]

  • 18. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
    Eick D, Polack A, Kofler E, Lenoir GM, Rickinson AB, Bornkamm GW.
    Oncogene; 1990 Sep 01; 5(9):1397-402. PubMed ID: 2216463
    [Abstract] [Full Text] [Related]

  • 19. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J, Meneceur P, Ray D, Moreau-Gachelin F.
    Cancer Res; 1988 Jul 15; 48(14):3972-6. PubMed ID: 3164254
    [Abstract] [Full Text] [Related]

  • 20. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines.
    Luo Y, Krause MO.
    J Cell Physiol; 1994 Aug 15; 160(2):303-15. PubMed ID: 8040189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.